Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

FDA Advisory Panel Recommends Approval of Drug for Preoperative Treatment of Breast Cancer

FDA Advisory Panel Recommends Approval of Drug for Preoperative Treatment of Breast Cancer News & Analysis lifelong complications, such as contracting gested that prescription opioid abuse was a databases to determine whether the patient hepatitis C. major contributor to the initiation of heroin is receiving opioid medications from another “It’s a catastrophic risk,” Fishman said. use. The new data from SAMHSA provide physician. Additionally, she recommended He urged clinicians to intervene aggres- strongerevidenceforsubstantialspilloverinto drawingupatreatmentagreementwithallopi- sively with individuals who are abusing pre- heroin use. oid patients to spell out the risks, benefits, scription pain medications, especially young Elinore F. McCance-Katz, MD, PhD, the goalsoftreatment,andpatientresponsibilities. people,whoareparticularlyvulnerabletosub- chiefmedicalofficerofSAMHSAandanaddic- Shenotedthatphysiciansshouldalsobe stance abuse. He said physicians should alert tiontreatmentspecialist,explainedinaninter- aware that there are effective treatment op- such patients to the risk of progression to il- viewthatbothprescriptionopioidsandheroin tions available for individuals addicted to licitdrugsandtherisksassociatedwiththem. affect the same brain receptors and produce heroinorprescriptionpainmedications.Two “Ifthereisanyuse,weoughttobejump- physical dependence. She noted that drug medications—naltrexone, an opioid antago- ing all over it and using it as an opportunity dealersmaysteerdrugseekerswhocannotaf- nist,andbuprenorphine-naloxone,whichre- for intervention,” he said. fordprescriptionmedicationstoheroin,which quires that the physician have a waiver from may be snorted initially or injected to deliver the Drug Enforcement Administration— Heroin Use Increasing a higher dose faster and more cheaply. can be prescribed by primary care physi- She http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

FDA Advisory Panel Recommends Approval of Drug for Preoperative Treatment of Breast Cancer

Jin, Jill
JAMA , Volume 310 (14) – Oct 9, 2013
Download PDF
1 page

FDA Advisory Panel Recommends Approval of Drug for Preoperative Treatment of Breast Cancer

Abstract

News & Analysis lifelong complications, such as contracting gested that prescription opioid abuse was a databases to determine whether the patient hepatitis C. major contributor to the initiation of heroin is receiving opioid medications from another “It’s a catastrophic risk,” Fishman said. use. The new data from SAMHSA provide physician. Additionally, she recommended He urged clinicians to intervene aggres- strongerevidenceforsubstantialspilloverinto...
Loading next page...
 
/lp/american-medical-association/fda-advisory-panel-recommends-approval-of-drug-for-preoperative-R6dSFJVFj1

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2013.280272
pmid
24104359
Publisher site
See Article on Publisher Site

Abstract

News & Analysis lifelong complications, such as contracting gested that prescription opioid abuse was a databases to determine whether the patient hepatitis C. major contributor to the initiation of heroin is receiving opioid medications from another “It’s a catastrophic risk,” Fishman said. use. The new data from SAMHSA provide physician. Additionally, she recommended He urged clinicians to intervene aggres- strongerevidenceforsubstantialspilloverinto drawingupatreatmentagreementwithallopi- sively with individuals who are abusing pre- heroin use. oid patients to spell out the risks, benefits, scription pain medications, especially young Elinore F. McCance-Katz, MD, PhD, the goalsoftreatment,andpatientresponsibilities. people,whoareparticularlyvulnerabletosub- chiefmedicalofficerofSAMHSAandanaddic- Shenotedthatphysiciansshouldalsobe stance abuse. He said physicians should alert tiontreatmentspecialist,explainedinaninter- aware that there are effective treatment op- such patients to the risk of progression to il- viewthatbothprescriptionopioidsandheroin tions available for individuals addicted to licitdrugsandtherisksassociatedwiththem. affect the same brain receptors and produce heroinorprescriptionpainmedications.Two “Ifthereisanyuse,weoughttobejump- physical dependence. She noted that drug medications—naltrexone, an opioid antago- ing all over it and using it as an opportunity dealersmaysteerdrugseekerswhocannotaf- nist,andbuprenorphine-naloxone,whichre- for intervention,” he said. fordprescriptionmedicationstoheroin,which quires that the physician have a waiver from may be snorted initially or injected to deliver the Drug Enforcement Administration— Heroin Use Increasing a higher dose faster and more cheaply. can be prescribed by primary care physi- She

Journal

JAMA – American Medical Association

Published: Oct 9, 2013

There are no references for this article.